This veto request letter explains that S.B. 2258 and S.B. 2301 will harm patients and raise drug prices in North Dakota by limiting PBM contracts with pharmacies that would allow underqualified pharmacies to dispense specialty drugs that generally are prescribed for a small segment of the population, require special care and handling, and are extremely expensive. These bills prohibit a PBM from requiring additional accreditation or recertification standards in addition to the state requirements for licensure in North Dakota. This prohibition is unprecedented nationally, jeopardizes patient safety, and interferes with private contracting, and is contrary to the Employee Retirement Income Security Act of 1974 (“ERISA”). The legislation also violates the Constitution of North Dakota.